Terms: = Kidney tumors AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Clinical Outcome
4 results:
1. Medical renal disease in tumor nephrectomies: The silent killer.
Tewari R; Bajaj R; Bharadwaj R
Saudi J Kidney Dis Transpl; 2018; 29(1):50-56. PubMed ID: 29456207
[TBL] [Abstract] [Full Text] [Related]
2. Diffuse proliferative glomerulonephritis associated with cetuximab, an epidermal growth factor receptor inhibitor.
Sasaki K; Anderson E; Shankland SJ; Nicosia RF
Am J Kidney Dis; 2013 Jun; 61(6):988-91. PubMed ID: 23474009
[TBL] [Abstract] [Full Text] [Related]
3. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
Schips L; Dalpiaz O; Lipsky K; Langner C; Rehak P; Puerstner P; Pummer K; Zigeuner R
Eur Urol; 2007 Jan; 51(1):168-73; discussion 174. PubMed ID: 16844285
[TBL] [Abstract] [Full Text] [Related]
4. Prednisolone and azathioprine in iga nephropathy - a ten-year follow-up study.
Goumenos DS; Davlouros P; El Nahas AM; Ahuja M; Shortland JR; Vlachojannis JG; Brown CB
Nephron Clin Pract; 2003; 93(2):C58-68. PubMed ID: 12616032
[TBL] [Abstract] [Full Text] [Related]
